Phase II study with the combination of mitomycin C, epirubicin and vincristine (MEV) as rescue treatment in previously treated metastatic breast cancer patients

1. Cruz Hernandez, J.J.
2. Garcia, J.
3. Fonseca, E.
4. Gomez, A.
5. Sanchez, P.
6. Martin, G.
7. Panadero, A.
8. Garcia, M.J.